Research map: Assessment of pricing, availability, and affordability of essential medicines in a resource-limited setting

Back to the article

Papers in this map

  1. Essential medicines for universal health coverage · Veronika J. Wirtz · 2016 · 653 citations · Cited by this paper
  2. Cost-utility and budget impact analysis of herpes zoster vaccines in Thai patients with end-stage renal disease · 2026 · Related
  3. Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia · Zaheer Ud Din Babar · 2007 · 201 citations · Cited by this paper
  4. Effectiveness of person-centred versus usual care in elderly patients: findings from a multicentre randomised controlled trial · 2026 · Related
  5. Pakistan's health system: performance and prospects after the 18th Constitutional Amendment · Sania Nishtar · 2013 · 183 citations · Cited by this paper
  6. Use of intravenous antibiotics for the management of suspected chorioamnionitis: insights from women's wellness and research center · 2026 · Related
  7. Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology · Lombe Kasonde · 2019 · 96 citations · Cited by this paper
  8. The impact of China’s National Drug Centralized Procurement Policy on pharmaceutical firm innovation: evidence from a staggered difference-in-differences analysis · 2026 · Related
  9. Access to Essential Medicines in Pakistan: Policy and Health Systems Research Concerns · Shehla Abbas Zaidi · 2013 · 94 citations · Cited by this paper
  10. The Saudi FDA drug evaluation timeline in comparison with international counterparts: a retrospective observational study · 2026 · Related
  11. Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs) · Zaheer‐Ud‐Din Babar · 2021 · 85 citations · Cited by this paper
  12. Community pharmacy based point-of-care testing for early detection of undiagnosed type 2 diabetes mellitus: a study protocol · 2026 · Related
  13. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology · Amna Saeed · 2019 · 79 citations · Cited by this paper
  14. Landscape of national antibiotic utilisation in Malaysia: an analysis of national pharmaceutical sales data from 2019 to 2023 · 2026 · Related
  15. Medicines and universal health coverage: challenges and opportunities · Maryam Bigdeli · 2015 · 64 citations · Cited by this paper
  16. Reconstructing the professional role of pharmacists in China from the perspective of public value theory: challenges and institutional pathways · 2026 · Related
  17. Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis · Lachlan Oldfield · 2024 · 48 citations · Cited by this paper
  18. Economic burden and health utility of transfusion-dependent beta-thalassemia in Thai adults: a societal perspective · 2026 · Related
  19. Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology · Mekonnen Sisay · 2021 · 41 citations · Cited by this paper
  20. A scoping review of the views and experiences of health professionals in the Middle East and North Africa regions regarding social media use · 2026 · Related
  21. Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan · Zaheer‐Ud‐Din Babar · 2022 · 39 citations · Cited by this paper
  22. Burden of noncommunicable diseases in Pakistan · Tahseen Haider Kazmi · 2022 · 39 citations · Cited by this paper
  23. Availability, prices and affordability of essential medicines: A cross-sectional survey in Hanam province, Vietnam · Thi Thanh Huong Nguyen · 2021 · 19 citations · Cited by this paper
  24. Pharmacy Practice and Policy Research in Pakistan: A Review of Literature Between 2014 and 2019 · Iram Malik · 2020 · 18 citations · Cited by this paper
  25. Availability of essential medicines in Pakistan—A comprehensive document analysis · Sunaina Rafi · 2021 · 17 citations · Cited by this paper
  26. The Pharmaceutical Industry, Intellectual Property Rights and Access to Medicines in Pakistan · Zaheer‐Ud‐Din Babar · 2013 · 14 citations · Cited by this paper
  27. The Crux of the Medicine Prices' Controversy in Pakistan · Kah S. Lee · 2017 · 14 citations · Cited by this paper
  28. A leap towards enforcing medicines prescribing by generic names in low- and middle-income countries (LMICs): pitfalls, limitations, and recommendations for local drug regulatory agencies · Hamid A. Merchant · 2022 · 14 citations · Cited by this paper
  29. Coping with increasing medicine costs through greater adoption of generic prescribing and dispensing in Pakistan as an exemplar country · Saad Abdullah · 2023 · 12 citations · Cited by this paper
  30. Assessment of prices, availability and affordability of essential medicines in Juba County, South Sudan · Justin Deng · 2023 · 10 citations · Cited by this paper
  31. Access to High Cost Medicines: An Overview · Syed Shahzad Hasan · 2018 · 7 citations · Cited by this paper
  32. Healthcare System of Pakistan: Strengths and Weaknesses · Akhtar Ali · 2021 · 7 citations · Cited by this paper
  33. Evaluation of Availability, Prices, and Affordability of Selected Essential Medicines in Balochistan, Pakistan · Murad Bibi · 2022 · 7 citations · Cited by this paper
  34. Developing Nepal’s medicines pricing policy: evidence synthesis and stakeholders’ consultation · Zaheer‐Ud‐Din Babar · 2024 · 7 citations · Cited by this paper
  35. Medicine Affordability and Accessibility: A Case of Low and Middle-Income Group of Gujranwala District · Khurram Shahzad · 2022 · 4 citations · Cited by this paper
  36. Availability and affordability of selected medicines in the Islamic Republic of Iran · Amir Reza Ghanbari · 2024 · 2 citations · Cited by this paper
  37. Trends in cancer burden in Pakistan: a 30-year analysis from the Global Burden of Disease Study (1990–2019) · Kamlesh M Bhojwani · 2026 · 2 citations · Cited by this paper
  38. Pharmaceutical multinational corporations (MNCs) and their exit from low and middle income countries (LMICs): analysing the causes and consequences · Muhammad Akhtar Abbas Khan · 2024 · 1 citation · Cited by this paper
  39. Pharmaceutical pricing policies: introduction, key concepts, and evidence synthesis · Zaheer‐Ud‐Din Babar · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)